153 related articles for article (PubMed ID: 1559296)
21. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules.
Papini E; Petrucci L; Guglielmi R; Panunzi C; Rinaldi R; Bacci V; Crescenzi A; Nardi F; Fabbrini R; Pacella CM
J Clin Endocrinol Metab; 1998 Mar; 83(3):780-3. PubMed ID: 9506726
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy of L-thyroxine (L-T4) therapy on the volume of the thyroid gland and nodules in patients with euthyroid nodular goiter (ENG)].
Diacinti D; Salabè GB; Olivieri A; D'Erasmo E; Tomei E; Lotz-Salabè H; De Martinis C
Minerva Med; 1992 Nov; 83(11):745-51. PubMed ID: 1461545
[TBL] [Abstract][Full Text] [Related]
23. [The effect of levothyroxine suppression therapy for benign thyroid nodules on bone metabolism in premenopausal women].
Akinci B; Demir T; Cömlekçi A; Karaoğlu O; Seçil M; Yeşil S
Kulak Burun Bogaz Ihtis Derg; 2008; 18(4):232-7. PubMed ID: 19052491
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of the effectiveness of two different dosages of levothyroxine-iodide combinations for the therapy of euthyroid diffuse goiter].
Kreissl M; Tiemann M; Hänscheid H; Rendl J; Reiners C
Dtsch Med Wochenschr; 2001 Mar; 126(9):227-31. PubMed ID: 11256036
[TBL] [Abstract][Full Text] [Related]
25. [Suppressive hormone therapy for thyroid nodules. Prospective evaluation. Preliminary results].
Wémeau JL; Cousty C; Vlaeminck V
Ann Endocrinol (Paris); 2000 May; 61(2):119-24. PubMed ID: 10891662
[TBL] [Abstract][Full Text] [Related]
26. Benign thyroid nodules respond to a single administration of 0.3mg recombinant human thyrotropin with highly variable volume increase.
Bountouris P; Markantes GK; Mamali I; Markou KB; Michalaki MA
Front Endocrinol (Lausanne); 2022; 13():1066379. PubMed ID: 36714577
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of thyroid nodule growth.
Quadbeck B; Pruellage J; Roggenbuck U; Hirche H; Janssen OE; Mann K; Hoermann R
Exp Clin Endocrinol Diabetes; 2002 Oct; 110(7):348-54. PubMed ID: 12397534
[TBL] [Abstract][Full Text] [Related]
28. [Medical Treatment of Thyroid Nodule].
Derwahl KM
Laryngorhinootologie; 2018 Feb; 97(2):89-91. PubMed ID: 29401546
[TBL] [Abstract][Full Text] [Related]
29. Short term effects of levothyroxine treatment in thyroid multinodular disease.
Cesareo R; Iozzino M; Isgrò MA; Annunziata F; Di Stasio E
Endocr J; 2010; 57(9):803-9. PubMed ID: 20683172
[TBL] [Abstract][Full Text] [Related]
30. Slow growth of benign thyroid nodules after menopause: no need for long-term thyroxine suppressive therapy in post-menopausal women.
Costante G; Crocetti U; Schifino E; Ludovico O; Capula C; Nicotera M; Arturi F; Filetti S
J Endocrinol Invest; 2004 Jan; 27(1):31-6. PubMed ID: 15053240
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of thyroxine-suppressive therapy and its relation to serum thyroglobulin levels in solitary nontoxic thyroid nodules.
Kuo SW; Hu CA; Pei D; Ni KB; Shian LR
J Formos Med Assoc; 1993 Jan; 92(1):55-60. PubMed ID: 8099828
[TBL] [Abstract][Full Text] [Related]
32. The effect of thyroxine-suppressive therapy in patients with solitary non-toxic thyroid nodules -- a randomised, double-blind, placebo-controlled study.
Tsai CC; Pei D; Hung YJ; Wang TF; Tsai WC; Yao CY; Hsieh MC; Kuo SW
Int J Clin Pract; 2006 Jan; 60(1):23-6. PubMed ID: 16409424
[TBL] [Abstract][Full Text] [Related]
33. Reduction of thyroid nodule volume by levothyroxine and iodine alone and in combination: a randomized, placebo-controlled trial.
Grussendorf M; Reiners C; Paschke R; Wegscheider K;
J Clin Endocrinol Metab; 2011 Sep; 96(9):2786-95. PubMed ID: 21715542
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis.
Castro MR; Caraballo PJ; Morris JC
J Clin Endocrinol Metab; 2002 Sep; 87(9):4154-9. PubMed ID: 12213864
[TBL] [Abstract][Full Text] [Related]
35. Thyroxine suppressive therapy in patients with nodular thyroid disease.
Gharib H; Mazzaferri EL
Ann Intern Med; 1998 Mar; 128(5):386-94. PubMed ID: 9490600
[TBL] [Abstract][Full Text] [Related]
36. Levothyroxine suppressive therapy in the medical management of nontoxic benign multinodular goiter.
Celani MF
Exp Clin Endocrinol; 1993; 101(5):326-32. PubMed ID: 8299711
[TBL] [Abstract][Full Text] [Related]
37. [Non-toxic nodular goiter: treatment and follow-up].
Mereu P; Scala M; Schenone F; Schenone G; Comandini D; Gipponi M; Margarino G
Acta Otorhinolaryngol Ital; 1995 Aug; 15(4):301-4. PubMed ID: 8928662
[TBL] [Abstract][Full Text] [Related]
38. The effect of treatment with levothyroxine or iodine on thyroid size and thyroid growth stimulating immunoglobulins in endemic goitre patients.
Wilders-Truschnig MM; Warnkross H; Leb G; Langsteger W; Eber O; Tiran A; Dobnig H; Passath A; Lanzer G; Drexhage HA
Clin Endocrinol (Oxf); 1993 Sep; 39(3):281-6. PubMed ID: 7900936
[TBL] [Abstract][Full Text] [Related]
39. Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine.
Hoermann R; Quadbeck B; Roggenbuck U; Szabolcs I; Pfeilschifter J; Meng W; Reschke K; Hackenberg K; Dettmann J; Prehn B; Hirche H; Mann K;
Thyroid; 2002 Dec; 12(12):1119-28. PubMed ID: 12593726
[TBL] [Abstract][Full Text] [Related]
40. Levothyroxine therapy in patients with thyroid disease.
Mandel SJ; Brent GA; Larsen PR
Ann Intern Med; 1993 Sep; 119(6):492-502. PubMed ID: 8357116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
